Predictors and short-term outcomes of hyperleukocytosis in children with acute myeloid leukemia: a report from the Children's Oncology Group
- PMID: 22801969
- PMCID: PMC3487455
- DOI: 10.3324/haematol.2012.065490
Predictors and short-term outcomes of hyperleukocytosis in children with acute myeloid leukemia: a report from the Children's Oncology Group
References
-
- Dutcher JP, Schiffer CA, Wiernik PH. Hyperleukocytosis in adult acute nonlymphocytic leukemia: impact on remission rate and duration, and survival. J Clin Oncol. 1987;5(9):1364-72 - PubMed
-
- Creutzig U, Zimmermann M, Ritter J, Reinhardt D, Hermann J, Henze G, et al. Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials. Leukemia. 2005;19(12):2030-42 - PubMed
-
- Greenwood MJ, Seftel MD, Richardson C, Barbaric D, Barnett MJ, Bruyere H, et al. Leukocyte count as a predictor of death during remission induction in acute myeloid leukemia. Leuk Lymphoma. 2006;47(7):1245-52 - PubMed
-
- Cooper TM, Franklin J, Gerbing RB, Alonzo TA, Hurwitz C, Raimondi SC, et al. AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the children's oncology group. Cancer. 2011;118(3):761-9 - PubMed
-
- Sung L, Aplenc R, Alonzo TA, Gerbing RB, Meshinchi S, Burden L, et al. Abstract: High mortality in extreme hyperleukocytosis in pediatric acute myeloid leukemia: a report from the Children's Oncology Group. American Society of Hematology, Orlando, Florida: 2010;116:1072
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
